+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Gastroparesis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767446
  • Report
  • April 2019
  • Region: Global
  • 106 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • AlfaSigma Srl
  • Eli Lilly and Company
  • Evoke Pharma Inc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Ocera Therapeutics Inc
  • MORE
The global clinical trial report- “2019 Gastroparesis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Gastroparesis. It presents in-depth analysis of Gastroparesis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Gastroparesis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Gastroparesis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Gastroparesis

The research work is prepared through extensive and continuous research on Gastroparesis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Gastroparesis patients are identified
  • The report includes panorama of Gastroparesis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Gastroparesis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AlfaSigma Srl
  • Eli Lilly and Company
  • Evoke Pharma Inc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Ocera Therapeutics Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Gastroparesis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Gastroparesis Clinical Trials by Region
2.2.2 Average Enrollment of Gastroparesis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Gastroparesis Treatment, 2019

3. Region wise Gastroparesis Clinical Trials
3.1 Asia Pacific Gastroparesis Clinical Trials by Country
3.2 Europe Gastroparesis Clinical Trials by Country
3.3 North America Gastroparesis Clinical Trials by Country
3.4 Middle East and Africa Gastroparesis Clinical Trials by Country
3.5 South and Central America Gastroparesis Clinical Trials by Country

4. Gastroparesis Clinical Trial Trends
4.1 Start Year wise Gastroparesis Clinical Trials
4.2 Phase wise Gastroparesis Clinical Trials
4.3 Trial Status wise Gastroparesis Clinical Trials
4.4 Trial Type wise Gastroparesis Clinical Trials

5. Gastroparesis Average Enrollment Trends
5.1 Average Enrollment in Gastroparesis Trials by Year
5.2 Average Enrollment in Gastroparesis Trials by Phase
5.3 Average Enrollment in Gastroparesis Trials by Status
5.4 Average Enrollment in Gastroparesis Trials by Type of Trial

6. Companies Participating in Gastroparesis Clinical Trials
6.1 Gastroparesis Trials by Sponsor Type
6.2 Gastroparesis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Gastroparesis Trials- Phase 1
7.2 Gastroparesis Trials- Phase 2
7.3 Gastroparesis Trials- Phase 3
7.4 Gastroparesis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Gastroparesis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Gastroparesis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Gastroparesis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Gastroparesis Clinical Trials and Enrolment
Figure 7: North America - Country wise Gastroparesis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Gastroparesis Clinical Trials and Enrolment
Figure 9: Gastroparesis Clinical Trials by Phase
Figure 10: Gastroparesis Clinical Trials by Trial Status
Figure 11: Gastroparesis Clinical Trials by Type
Figure 12: Gastroparesis Clinical Trials by Sponsor Type
Figure 13: Gastroparesis Clinical Trials by Leading Sponsors
Figure 14: Gastroparesis Average Enrollment by Phase
Figure 15: Gastroparesis Average Enrollment by Trial Status
Figure 16: Gastroparesis Average Enrollment by Type
Figure 17: Gastroparesis- Average Enrolment by Type of Sponsors
Figure 18: Gastroparesis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Gastroparesis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Gastroparesis Clinical Trials and Enrolment
Table 5: Europe - Country wise Gastroparesis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Gastroparesis Clinical Trials and Enrolment
Table 7: North America - Country wise Gastroparesis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Gastroparesis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Gastroparesis Average Enrollment by Phase
Table 15: Gastroparesis Average Enrollment by Trial Status
Table 16: Gastroparesis Average Enrollment by Type
Table 17: Gastroparesis- Average Enrolment by Type of Sponsors
Table 18: Gastroparesis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • AlfaSigma Srl
  • Eli Lilly and Company
  • Evoke Pharma Inc
  • GlaxoSmithKline Plc
  • Ironwood Pharmaceuticals Inc
  • Johnson & Johnson
  • Ocera Therapeutics Inc
  • RaQualia Pharma Inc
  • Rhythm Holding Company LLC
  • Shire Plc
Note: Product cover images may vary from those shown
Adroll
adroll